---
title: Accelsiors vs Fortrea
slug_a: accelsiors
slug_b: fortrea
site: cro
review_signal_gate: closed
canonical_path: /compare/accelsiors/fortrea
---

# Accelsiors vs Fortrea

Side-by-side profile data from each company listing on this directory.

## Accelsiors

- Profile: [/companies/accelsiors](/companies/accelsiors)

Accelsiors — Full-service CRO providing clinical trial management, regulatory consulting, pharmacovigilance, biostatistics, and medical writing across 40+ countries with AI-secure eClinical systems and patient-centered trial design.

Services: 14. Modalities: 7. Indications: 9. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (14).

### Services

- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Regulatory Affairs
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
- Japan PMDA Regulatory Strategy
- China NMPA Regulatory Strategy

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Cell Therapy
- Gene Therapy
- Vaccine
- Microbiome Therapeutic

### Indications

- Oncology
- Immunology
- Neurology
- Infectious Disease
- Rare Disease
- Respiratory
- Gastroenterology
- Nephrology
- Women's Health

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Functional Service Provider (FSP)

## Fortrea

- Profile: [/companies/fortrea](/companies/fortrea)

Fortrea — Fortrea is a leading CRO advancing clinical trials through patient-focused clinical solutions that accelerate clinical development and drive trial success.

Services: 17. Modalities: 6. Indications: 13. Locations: 54. Certifications: 2. The strongest documented coverage currently appears in locations (54).

### Services

- Clinical Trial Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Central Laboratory Services
- Clinical Imaging Core Lab
- Regulatory Affairs
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
- Japan PMDA Regulatory Strategy
- China NMPA Regulatory Strategy

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Cell Therapy
- Gene Therapy
- Vaccine

### Indications

- Oncology
- Immunology
- Neurology
- Metabolic
- Cardiovascular
- Infectious Disease
- Rare Disease
- Respiratory
- Dermatology
- Ophthalmology
- Gastroenterology
- Nephrology
- Women's Health

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV
- Real-World Evidence (RWE) / Registries

### Sourcing models

- Functional Service Provider (FSP)
- Full-Service Outsourcing (FSO)